FDA NDC Directory · JSON-LD · Markdown

BORTEZOMIB

NDC 70771-1708 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA210204
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (1 mg/mL)
Marketing started20220502
Package count1

External sources

Source: openFDA. Public-domain (CC0).